{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Brand", "Clopidogrel", "Generic", "Platelet Aggregation", "Stable Angina"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "29391931", "DateRevised": {"Year": "2020", "Month": "09", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "10", "Day": "10"}], "Language": ["eng"], "ELocationID": ["10.15171/jcvtr.2017.33"], "Journal": {"ISSN": "2008-5117", "JournalIssue": {"Volume": "9", "Issue": "4", "PubDate": {"Year": "2017"}}, "Title": "Journal of cardiovascular and thoracic research", "ISOAbbreviation": "J Cardiovasc Thorac Res"}, "ArticleTitle": "In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris.", "Pagination": {"StartPage": "191", "EndPage": "195", "MedlinePgn": "191-195"}, "Abstract": {"AbstractText": ["<i><b>Introduction:</b></i> Clopidogrel is a potent platelet activation and aggregation inhibitor that prevents thrombosis in coronary artery diseases (CADs). In comparison to locally produced generic one (Osvix\u00ae), original brand of clopidogrel (Plavix\u00ae) is expensive. This study was designed to evaluate the effectiveness and uniformity of Osvix\u00ae versus Plavix\u00ae in patients with percutaneous coronary intervention (PCI) by means of platelet aggregation indexes. <i><b>Methods:</b></i> This randomized, double blind clinical study was conducted at Shahid Madani heart hospital, Tabriz, Iran, and 129 patients with previous PCI were enrolled in two independent treatment groups. All patients participated in this study were on dual antiplatelet therapy at least for 30 days. ASA 80 mg/d and clopidogrel 75 mg/d and a stat dose of 300 mg of clopidogrel before PCI were administered for all patients. To evaluate the anti-platelet activity, blood samples were taken from the patients and platelet aggregation test was performed. <i><b>Results:</b></i> The total study population represents a group of 129 patients (99 men and 30 women) with mean age of 57.7 \u00b1 9.7 years with stable angina pectoris. The baseline characteristics and laboratory findings of two groups (except mean platelet volume [MPV]) were not different statistically. The mean platelets aggregation at 30th day was 13.7\u00b17.0 in Plavix\u00ae group and 14.8\u00b15.8 in Osvix\u00ae group (<i>P</i> value\u2005=\u20050.35). <i><b>Conclusion:</b></i> This study showed that Osvix\u00ae as a generic form of clopidogrel was not significantly different from the original brand (Plavix) in terms of in vitro platelet inhibition."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Hajizadeh", "ForeName": "Rza", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Ghaffari", "ForeName": "Samad", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plant Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}], "LastName": "Ziaee", "ForeName": "Mojtaba", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Shokouhi", "ForeName": "Behrooz", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Separham", "ForeName": "Ahmad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Sarbakhsh", "ForeName": "Parvin", "Initials": "P"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "J Cardiovasc Thorac Res", "NlmUniqueID": "101528712", "ISSNLinking": "2008-5117"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2095\u2013128. doi: 10.1016/S0140-6736(12)61728-0.", "ArticleIdList": ["10.1016/S0140-6736(12)61728-0", "23245604"]}, {"Citation": "Ziaee M, Khorrami A, Nourafcan H, Ebrahimi M, Amiraslanzadeh M, Garjani M. et al. Cardioprotective effects of essential oil of Lavandula angustifolia on isoproterenol-induced acute myocardial infarction in rat. Iran J Pharm Res. 2015;14(1):279\u201389.", "ArticleIdList": ["PMC4277641", "25561934"]}, {"Citation": "Moran AE, Forouzanfar MH, Roth G, Mensah GA, Ezzati M, Flaxman A. et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129(14):1493\u2013501. doi: 10.1161/CIRCULATIONAHA.113.004046.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.113.004046", "PMC4181601", "24573351"]}, {"Citation": "Badimon L, Padr\u00f3 T, Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J. 2012;1:60\u201374. doi: 10.1177/2048872612441582.", "ArticleIdList": ["10.1177/2048872612441582", "PMC3760546", "24062891"]}, {"Citation": "Jernberg T, Payne CD, Winters KJ, Darstein C, Brandt JT, Jakubowski JA. et al. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J. 2006;27:1166\u201373. doi: 10.1093/eurheartj/ehi877.", "ArticleIdList": ["10.1093/eurheartj/ehi877", "16621870"]}, {"Citation": "Tsoumani ME, Kalantzi KI, Goudevenos IA, Tselepis AD. Clopidogrel generic formulations in the era of new antiplatelets: a systematic review. Curr Vasc Pharmacol. 2014;12(5):766\u201377.", "ArticleIdList": ["23885646"]}, {"Citation": "HajiAghajani M, Kobarfard F, Safi O, Sheibani K, Sistanizad M. Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention. Iran J Pharm Res. 2013;12:169\u201374.", "ArticleIdList": ["PMC3813374", "24250685"]}, {"Citation": "Khosravi AR, Pourmoghadas M, Ostovan M, Mehr GK, Gharipour M, Zakeri H. et al. The impact of generic form of Clopidogrel on cardiovascular events in patients with coronary artery stent: results of the OPCES study. J Res Med Sci. 2011;16:640.", "ArticleIdList": ["PMC3214376", "22091287"]}, {"Citation": "Manzoli L, Flacco ME, Boccia S, D\u2019Andrea E, Panic N, Marzuillo C. et al. Generic versus brand-name drugs used in cardiovascular diseases. Eur J Epidemiol. 2016;31(4):351\u201368. doi: 10.1007/s10654-015-0104-8.", "ArticleIdList": ["10.1007/s10654-015-0104-8", "PMC4877434", "26620809"]}, {"Citation": "Souri E, Jalalizadeh H, Kebriaee\u2010Zadeh A, Shekarchi M, Dalvandi A. Validated HPLC method for determination of carboxylic acid metabolite of clopidogrel in human plasma and its application to a pharmacokinetic study. Biomed Chromatogr. 2006;20:1309\u201314. doi: 10.1002/bmc.697.", "ArticleIdList": ["10.1002/bmc.697", "16977589"]}, {"Citation": "Imani B, Safi-Ariyan R, Manaafi B, Karampourian A, Ghazikhanlou Sani K. The effectiveness, side effects and acceptability of locally available brand of Clopidogrel (Osvix) as antiplatelet tablet in CABG patients. Tehran Univ Med J. 2014;72:207\u201314."}, {"Citation": "Shrank WH, Liberman JN, Fischer MA, Girdish C, Brennan TA, Choudhry NK. Physician perceptions about generic drugs. Ann Pharmacother. 2011;45:31\u20138. doi: 10.1345/aph.1P389.", "ArticleIdList": ["10.1345/aph.1P389", "21205953"]}, {"Citation": "Hassali MA, Shafie AA, Jamshed S, Ibrahim MI, Awaisu A. Consumers\u2019 views on generic medicines: a review of the literature. Int J Pharm Pract. 2009;17:79\u201388.", "ArticleIdList": ["20214255"]}, {"Citation": "Burnouf T, Goubran HA, Chou M-L, Devos D, Radosevic M. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev. 2014;28:155\u201366. doi: 10.1016/j.blre.2014.04.002.", "ArticleIdList": ["10.1016/j.blre.2014.04.002", "24826991"]}, {"Citation": "Brydon L, Magid K, Steptoe A. Platelets, coronary heart disease, and stress. Brain Behav Immun. 2006;20:113\u20139. doi: 10.1016/j.bbi.2005.08.002.", "ArticleIdList": ["10.1016/j.bbi.2005.08.002", "16183245"]}, {"Citation": "Capodanno D , Angiolillo DJ . Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation. 2013;128:2785\u201398. doi: 10.1161/CIRCULATIONAHA.113.003675.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.113.003675", "24366588"]}, {"Citation": "Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herrman J-P. et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381:1107\u201315. doi: 10.1016/S0140-6736(12)62177-1.", "ArticleIdList": ["10.1016/S0140-6736(12)62177-1", "23415013"]}, {"Citation": "Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;2001:494\u2013502. doi: 10.1056/NEJMoa010746.", "ArticleIdList": ["10.1056/NEJMoa010746", "11519503"]}, {"Citation": "Bertrand ME, Rupprecht H-J, Urban P, Gershlick AH. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting the clopidogrel aspirin stent international cooperative study (CLASSICS) Circulation. 2000;102:624\u20139.", "ArticleIdList": ["10931801"]}, {"Citation": "Choudhry NK, Levin R, and Avorn J. The economic consequences of non\u2013evidence-based clopidogrel use. Am Heart J. 2008;155:904\u20139. doi: 10.1016/j.ahj.2007.11.039.", "ArticleIdList": ["10.1016/j.ahj.2007.11.039", "18440340"]}, {"Citation": "Brandt JT, Payne CD, Wiviott SD, Weerakkody G, Farid NA, Small DS. et al. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am Heart J. 2007;153:66 e9\u201316. doi: 10.1016/j.ahj.2006.10.010.", "ArticleIdList": ["10.1016/j.ahj.2006.10.010", "17174640"]}, {"Citation": "Kesselheim AS. Off-label drug use and promotion: balancing public health goals and commercial speech. Am J Law Med. 2011;37(2-3):225\u201357. doi: 10.1177/009885881103700202.", "ArticleIdList": ["10.1177/009885881103700202", "21847880"]}, {"Citation": "Khosravi AR, Raoufi A, Pourmoghadas M, Paydari N, Gharipour M, Namdari M. et al. Late clinical events of drug eluting versus bare metal stenting; OPCES\u2019ancillary study. Pak J Med Sci. 2013;29(1):258\u201363."}, {"Citation": "Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol. 2004;44:1945\u201356. doi: 10.1016/j.jacc.2004.07.056.", "ArticleIdList": ["10.1016/j.jacc.2004.07.056", "15542275"]}, {"Citation": "\u015eahin DY, Elbasan Z, G\u00fcr M, Y\u0131ld\u0131z A, Akp\u0131nar O, Icen YK. et al. Neutrophil to lymphocyte ratio is associated with the severity of coronary artery disease in patients with ST-segment elevation myocardial infarction. Angiology. 2013;64:423\u20139. doi: 10.1177/0003319712453305.", "ArticleIdList": ["10.1177/0003319712453305", "22802534"]}, {"Citation": "Chu S, Becker R, Berger P, Bhatt D, Eikelboom J, Konkle B. et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta\u2010analysis. J Thromb Haemost. 2010;8:148\u201356. doi: 10.1111/j.1538-7836.2009.03584.x.", "ArticleIdList": ["10.1111/j.1538-7836.2009.03584.x", "PMC3755496", "19691485"]}, {"Citation": "Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke. 2004;35:1688\u201391. doi: 10.1161/01.STR.0000130512.81212.a2.", "ArticleIdList": ["10.1161/01.STR.0000130512.81212.a2", "15143290"]}]}], "History": [{"Year": "2017", "Month": "4", "Day": "13"}, {"Year": "2017", "Month": "9", "Day": "18"}, {"Year": "2018", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29391931", "PMC5787330", "10.15171/jcvtr.2017.33"]}}]}